what should be monitored in a child receiving chemotherapy

HESI LPN

LPN Nutrition Practice Test

1. What should be monitored in a child receiving chemotherapy?

A. Blood glucose levels
B. Blood cell counts
C. Weight gain
D. Skin elasticity

Correct answer: B

Rationale: The correct answer is monitoring blood cell counts. During chemotherapy, it is crucial to monitor blood cell counts to detect potential side effects such as neutropenia (low white blood cell count) and anemia (low red blood cell count). These conditions can increase the risk of infections and fatigue. Monitoring blood glucose levels (Choice A) is not typically a primary concern in children receiving chemotherapy unless they have pre-existing conditions like diabetes. Weight gain (Choice C) and skin elasticity (Choice D) are not directly related to monitoring the effects of chemotherapy in children. Therefore, the most important parameter to monitor in a child receiving chemotherapy is blood cell counts.

2. What is an important aspect of managing a child with chronic kidney disease?

A. Monitoring electrolyte levels
B. Increasing protein intake
C. Limiting fluid intake
D. Encouraging a high-fat diet

Correct answer: A

Rationale: Monitoring electrolyte levels is crucial in managing chronic kidney disease in children because imbalances can lead to serious complications. Electrolyte levels must be carefully monitored to prevent issues such as electrolyte abnormalities, which can further impact kidney function and overall health. Choices B, C, and D are incorrect because increasing protein intake, limiting fluid intake, and encouraging a high-fat diet can exacerbate kidney disease in children by putting extra strain on their kidneys or causing other health problems.

3. Why is randomization important in a scientific experiment?

A. To minimize the impact of confounding variables.
B. To eliminate bias in the assignment of subjects to groups.
C. To contribute to the accuracy and validity of the experiment's results.
D. To prevent systematic differences between groups.

Correct answer: B

Rationale: Randomization is crucial in a scientific experiment to eliminate bias in the assignment of subjects to groups. By randomly assigning subjects, it helps ensure that any differences observed in the outcomes are due to the experimental treatment and not to preexisting differences between groups. Choice A is incorrect because randomization does not guarantee representativeness but rather minimizes the impact of confounding variables. Choice C is not entirely accurate; while randomization can contribute to accuracy and validity, its primary purpose is to reduce bias. Choice D is incorrect as the goal of randomization is not to balance the number of subjects but to prevent systematic differences between groups.

4. Which medication is typically used for long-term control of asthma?

A. Albuterol
B. Theophylline
C. Ipratropium
D. Prednisone

Correct answer: B

Rationale: The correct answer is B, Theophylline. Theophylline is commonly used for long-term control of asthma by relaxing the muscles around the airways to keep them open, making breathing easier. Albuterol (choice A) is a short-acting bronchodilator for quick relief of asthma symptoms, not for long-term control. Ipratropium (choice C) is another short-acting bronchodilator that helps open the airways but is not typically used for long-term control. Prednisone (choice D) is a corticosteroid usually used for short periods to control asthma exacerbations or flare-ups, not as a long-term control medication.

5. Which lab result should be abnormal in a child with hemophilia?

A. Prothrombin time
B. Bleeding time
C. Platelet count
D. Partial thromboplastin time

Correct answer: D

Rationale: In a child with hemophilia, the lab result that should be abnormal is the partial thromboplastin time (PTT). Hemophilia is a disorder that affects the clotting factors in the intrinsic pathway of coagulation, leading to a prolonged PTT. Prothrombin time (Choice A) assesses the extrinsic pathway and should be normal in hemophilia. Bleeding time (Choice B) evaluates platelet function, which is typically normal in hemophilia. Platelet count (Choice C) measures the number of platelets and is not directly affected by hemophilia.